Trump Drugmaker Deals Could Save $529 Billion Over 10 Years, White House Says
The White House announced that agreements brokered by Donald Trump with pharmaceutical companies could save the U.S. economy up to $529 billion over the next decade, positioning the deals as a major effort to curb rising drug costs.
What Happened
According to a report by CTV News, officials said the voluntary agreements with drug manufacturers are designed to lower prescription prices and expand access to affordable medications.
The projected savings figure—$529 billion over 10 years—marks one of the most ambitious claims tied to recent healthcare cost reforms.
Key Details
Structure of the Drugmaker Deals
The agreements reportedly include:
Price caps or reductions on select medications
Increased transparency in pricing
Expanded patient access programs
Offici...



















